Septalyst Lifesciences Private Limited, a active private limited company, was established on 10 June 2010 in Thane, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74900MH2010PTC203994. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.23 M.
It upholds a compliant status. Employing 131 professional, Its leadership includes Shyam Sunder Singh (Managing Director), Bhaskar Shivprasad Mamgai (Director), Ajeet Singh (Director). Past directors included Shyam Sunder Singh, Bhaskar Shivprasad Mamgai, Ajeet Singh. It holds ₹17.15 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 801-802, B Wing, Lodha Supremus, Kolshet Road, Thane, Thane, Maharashtra, 400607.
U74900MH2010PTC203994
203994
10 June 2010
₹0.50 M
₹0.23 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Septalyst Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shyam Sunder Singh | Managing Director | 10 Jun 2010 | Current |
| Bhaskar Shivprasad Mamgai | Director | 26 Oct 2021 | Current |
| Ajeet Singh | Director | 26 Oct 2021 | Current |
| Vishal Gourav Bohidar | Director | 10 Jun 2010 | Current |
| Yogesh Prabhudyal Sharma | Director | 10 Jun 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 19 Dec 2018 | Past |
| Pramod Abcsdd | Director | 29 Nov 2021 | Past |
| Pramod Abcsdd | Director | 29 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Septalyst Lifesciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 27.97% increase. The company also saw a substantial improvement in profitability, with a 22.02% increase in profit. The company's net worth moved up by a moderate rise of 4.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Septalyst Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹171,480,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jun 2025 | Others | ₹4.90 Cr | Open |
| 02 Jun 2025 | Others | ₹1.76 Cr | Open |
| 27 Jul 2022 | Others | ₹2.45 Cr | Open |
| 27 Jul 2022 | Others | ₹6.50 Cr | Open |
| 08 Feb 2021 | Hdfc Bank Limited | ₹4.31 M | Open |
Explore comprehensive loan charge details -
Septalyst Lifesciences has a workforce of 131 employees as of Dec 16, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Septalyst Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Septalyst Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others of Rs. 49.00 M registered on 02 Jun 2025 with Charge ID 101116436 was modified on 29 Jul 2025. was completed.
A charge with Others of Rs. 17.62 M registered on 02 Jun 2025 with Charge ID 101116433 was modified on 29 Jul 2025. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 49.00 M with Charge ID 101116436 was registered on 02 Jun 2025. was completed.
Progress on A charge with Others amounted to Rs. 17.62 M with Charge ID 101116433 was registered on 02 Jun 2025. was documented.
Septalyst Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Septalyst Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The CIN of Septalyst Lifesciences Private Limited is U74900MH2010PTC203994.
Septalyst Lifesciences Private Limited is headquartered at 801-802, B Wing, Lodha Supremus, Kolshet Road, Thane, Thane, Maharashtra, 400607.
Septalyst Lifesciences Private Limited was incorporated on 10 June 2010.
The current directors of Septalyst Lifesciences Private Limited are
The primary industry of Septalyst Lifesciences Private Limited is Trade.
Septalyst Lifesciences Private Limited is unlisted.
The authorized capital of Septalyst Lifesciences Private Limited is ₹0.50 M, and the paid-up capital is ₹0.23 M.
The compliance status of Septalyst Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX